BR112023021345A2 - Produto de ovo hiperimunizado para tratamento ou prevenção de doença hepática alcoólica e doença enxerto contra hospedeiro - Google Patents
Produto de ovo hiperimunizado para tratamento ou prevenção de doença hepática alcoólica e doença enxerto contra hospedeiroInfo
- Publication number
- BR112023021345A2 BR112023021345A2 BR112023021345A BR112023021345A BR112023021345A2 BR 112023021345 A2 BR112023021345 A2 BR 112023021345A2 BR 112023021345 A BR112023021345 A BR 112023021345A BR 112023021345 A BR112023021345 A BR 112023021345A BR 112023021345 A2 BR112023021345 A2 BR 112023021345A2
- Authority
- BR
- Brazil
- Prior art keywords
- hyperimmunized
- graft
- versus
- alcoholic liver
- disease
- Prior art date
Links
- 208000022309 Alcoholic Liver disease Diseases 0.000 title abstract 4
- 208000009329 Graft vs Host Disease Diseases 0.000 title abstract 4
- 208000024908 graft versus host disease Diseases 0.000 title abstract 4
- 230000002265 prevention Effects 0.000 title abstract 2
- 235000013601 eggs Nutrition 0.000 abstract 8
- 241000194032 Enterococcus faecalis Species 0.000 abstract 3
- 229940032049 enterococcus faecalis Drugs 0.000 abstract 3
- 241000194031 Enterococcus faecium Species 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 239000003053 toxin Substances 0.000 abstract 2
- 231100000765 toxin Toxicity 0.000 abstract 2
- 108010036967 Enterococcus faecalis cytolysin Proteins 0.000 abstract 1
- 102000004503 Perforin Human genes 0.000 abstract 1
- 108010056995 Perforin Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
produto de ovo hiperimunizado para tratamento ou prevenção de doença hepática alcoólica e doença enxerto contra hospedeiro. em um aspecto, a presente invenção é direcionada a um método para prevenir ou tratar doença hepática alcoólica ou doença enxerto contra hospedeiro em um indivíduo com necessidade do mesmo, compreendendo administrar ao indivíduo uma quantidade terapeuticamente eficaz de um produto de ovo hiperimunizado obtido a partir de um animal produtor de ovos, prevenindo ou tratando assim a doença hepática alcoólica ou a doença enxerto contra hospedeiro no indivíduo, em que o produto de ovo hiperimunizado compreende uma quantidade terapeuticamente eficaz de um ou mais anticorpos para um antígeno selecionado a partir do grupo que consiste em enterococcus faecalis, toxina de citolisina de enterococcus faecalis, e enterococcus faecium. a presente invenção também é direcionada a ovos hiperimunizados e produtos de ovos produzidos por um animal que foi hiperimunizado com um antígeno selecionado a partir do grupo que consiste em enterococcus faecalis, toxina de citolisina isolada de enterococcus faecalis, e enterococcus faecium. métodos de preparação de ovos hiperimunizados e produtos de ovos também são descritos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163175603P | 2021-04-16 | 2021-04-16 | |
| PCT/US2022/024946 WO2022221616A1 (en) | 2021-04-16 | 2022-04-15 | Hyperimmunized egg product for treating or preventing alcoholic liver disease and graft-versus-host disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023021345A2 true BR112023021345A2 (pt) | 2023-12-19 |
Family
ID=81926046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023021345A BR112023021345A2 (pt) | 2021-04-16 | 2022-04-15 | Produto de ovo hiperimunizado para tratamento ou prevenção de doença hepática alcoólica e doença enxerto contra hospedeiro |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4322973A1 (pt) |
| KR (1) | KR20230172005A (pt) |
| CN (1) | CN117440818A (pt) |
| AU (1) | AU2022258701A1 (pt) |
| BR (1) | BR112023021345A2 (pt) |
| CA (1) | CA3215464A1 (pt) |
| CO (1) | CO2023014297A2 (pt) |
| IL (1) | IL307440A (pt) |
| WO (1) | WO2022221616A1 (pt) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3461840A1 (en) * | 2009-04-27 | 2019-04-03 | Immuron Limited | Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of non alcoholic steatohepatitis |
| AU2011332053B2 (en) * | 2010-11-23 | 2016-06-02 | Pantheryx, Inc. | Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications |
| US10632158B2 (en) * | 2016-06-23 | 2020-04-28 | IgY Nutrition | Use of a hyperimmune egg product to prevent and treat dysbiosis |
-
2022
- 2022-04-15 IL IL307440A patent/IL307440A/en unknown
- 2022-04-15 CN CN202280036488.6A patent/CN117440818A/zh active Pending
- 2022-04-15 BR BR112023021345A patent/BR112023021345A2/pt unknown
- 2022-04-15 KR KR1020237039461A patent/KR20230172005A/ko unknown
- 2022-04-15 EP EP22726551.9A patent/EP4322973A1/en active Pending
- 2022-04-15 AU AU2022258701A patent/AU2022258701A1/en active Pending
- 2022-04-15 WO PCT/US2022/024946 patent/WO2022221616A1/en active Application Filing
- 2022-04-15 CA CA3215464A patent/CA3215464A1/en active Pending
-
2023
- 2023-10-25 CO CONC2023/0014297A patent/CO2023014297A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL307440A (en) | 2023-12-01 |
| CO2023014297A2 (es) | 2023-10-30 |
| CA3215464A1 (en) | 2022-10-20 |
| EP4322973A1 (en) | 2024-02-21 |
| WO2022221616A1 (en) | 2022-10-20 |
| CN117440818A (zh) | 2024-01-23 |
| AU2022258701A1 (en) | 2023-10-26 |
| KR20230172005A (ko) | 2023-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Abbas et al. | IgY antibodies for the immunoprophylaxis and therapy of respiratory infections | |
| BR112022006205A2 (pt) | Oligonucleotídeo; composição farmacêutica; composição de oligonucleotídeo; fosforamidita; método de preparação de um oligonucleotídeo ou composição; método para caracterizar um oligonucleotídeo ou uma composição; método para modificar uma adenosina alvo em um ácido nucleico alvo; método para desaminar uma adenosina alvo em um ácido nucleico alvo; método para prevenção ou tratamento de uma afecção, distúrbio ou doença passível de uma mutação de g para a; e composto, oligonucleotídeo, composição ou método | |
| AR103868A1 (es) | Anticuerpos anti-cd47 como agentes terapéuticos | |
| AR080564A1 (es) | Metodos para el tratamiento o prevencion de enfermedades asociadas al receptor del factor de crecimiento epidermico humano-3 (her-3) | |
| KR100617415B1 (ko) | 항 닭 콕시듐증 조성물 | |
| MX2019009554A (es) | Producto de huevo hiperinmunizado para el tratamiento de enteritis necrotica en aves de corral. | |
| JP2023103316A (ja) | ＥＭＳ／ＡＨＰＮＤに対する防御効果を提供するＩｇＹ抗体含有餌料 | |
| RU2689386C2 (ru) | ЭМУЛЬГИРОВАННАЯ ВАКЦИНА ДЛЯ ПОЛУЧЕНИЯ КОНЦЕНТРИРОВАННЫХ КОМПОЗИЦИЙ ИММУНОГЛОБУЛИНОВ IgY; СПОСОБЫ И ИХ ПРИМЕНЕНИЯ | |
| JP2016514099A5 (pt) | ||
| RU2017145662A (ru) | Моноклональные антитела и способы их применения | |
| CN111349156A (zh) | 牛犊消化系统疾病的预防或治疗用卵黄抗体的制造方法以及由此而制造的卵黄抗体及其用途 | |
| BR112023021345A2 (pt) | Produto de ovo hiperimunizado para tratamento ou prevenção de doença hepática alcoólica e doença enxerto contra hospedeiro | |
| CN111217906A (zh) | 猪消化系统疾病的预防或治疗用卵黄抗体的制造方法以及基于此而制造的卵黄抗体及其用途 | |
| Gujral et al. | A combination of egg yolk IgY and phosvitin inhibits the growth of enterotoxigenic escherichia coli K88 and K99 | |
| Kang et al. | Effects of the routine multiple vaccinations on the expression of innate immune molecules and induction of histone modification in ovarian cells of layer chicks | |
| Li et al. | Egg yolk IgY against RHDV capsid protein VP60 promotes rabbit defense against RHDV infection | |
| JP2017506503A5 (pt) | ||
| RU2016134909A (ru) | Вакцины на основе реовирусов птиц | |
| WO2010044451A1 (ja) | 魚類のスクーチカ症予防治療ワクチン | |
| JP2008169142A (ja) | 食中毒菌に対する抗体の産生方法 | |
| US20220362203A1 (en) | Method for treating mood disorders | |
| Sudjarwo et al. | Production and characterization protein of anti HIV specific immunoglobulin Y for Immunotherapy | |
| ATE359820T1 (de) | Verwendung von vogelantikörpern | |
| Efimenko et al. | Approaches of growing chicken at poultry plants for food industry | |
| JP6712760B2 (ja) | サルモネラワクチン |